Proceedings of a Consensus Conference: Pathogen Inactivation—Making Decisions About New Technologies
- 6 December 2007
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 22 (1), 1-34
- https://doi.org/10.1016/j.tmrv.2007.09.001
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalenTransfusion, 2007
- Quality and safety of fresh‐frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years’ experienceVox Sanguinis, 2007
- Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregationJournal of Clinical Investigation, 2006
- In vivorecovery and survival of red cells after photodynamic treatment with thiopyrylium and red light using a canine modelVox Sanguinis, 2006
- A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh‐frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraTransfusion, 2006
- Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizerVox Sanguinis, 2006
- Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopeniaTransfusion, 2006
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialBlood, 2004
- Methylene blue‐photoinactivated plasma vs. fresh‐frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpuraVox Sanguinis, 2004
- Current performance of patient sample collection in the UKTransfusion Medicine, 2004